NHU(SZ:002001) Guoxin Securities·2025-10-29 01:51Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][6][18] Core Views - The company has demonstrated strong resilience in its third-quarter performance, with a notable increase in net profit despite a decline in revenue [1][8] - The production of liquid methionine has successfully commenced, contributing to the company's growth potential [4][12] - The company is expected to benefit from the rising prices of methionine and the expansion of its production capacity, positioning it as a global leader in the industry [4][12] Financial Performance - For the first three quarters of 2025, the company achieved revenue of 16,642 million yuan, a year-on-year increase of 5.45%, and a net profit of 5,321 million yuan, up 33.37% year-on-year [8] - The sales gross margin was 45.55%, and the net profit margin was 31.97%, indicating strong profitability [8] - In the third quarter alone, the company reported revenue of 5,541 million yuan, a year-on-year decrease of 6.66%, and a net profit of 1,717 million yuan, down 3.80% year-on-year [8] Methionine Production and Market Trends - The solid methionine market price reached 20,800 yuan per ton, with a year-to-date increase of 5.85% [4][12] - The company is expanding its methionine production capacity to 460,000 tons per year, which will rank it third globally [4][12] - The methionine industry has seen a significant increase in demand and prices since 2024, providing strong support for the company's revenue growth [4][12] Vitamin Business Performance - The prices of VA and VE have declined significantly, but the company's profitability remains stable, with a net profit margin of 58.00% for its vitamin subsidiary [5][16] - The company expects the vitamin business to maintain a steady profit level despite recent price fluctuations [5][16] Investment Recommendations - The report maintains the "Outperform the Market" rating, highlighting the company's strong operational performance and growth potential across various business segments [6][18] - The projected net profits for 2025-2027 are 6,792 million, 7,248 million, and 7,737 million yuan, respectively, with corresponding PE ratios of 10.6, 9.9, and 9.3 times [6][18]